Class information for:
Level 1: JOURNAL OF CYSTIC FIBROSIS//INHALED TOBRAMYCIN//PULMONARY EXACERBATION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2089 2293 39.1 70%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
660 12667 CYSTIC FIBROSIS//CFTR//JOURNAL OF CYSTIC FIBROSIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 JOURNAL OF CYSTIC FIBROSIS Journal 25 17% 6% 136
2 INHALED TOBRAMYCIN Author keyword 21 85% 0% 11
3 PULMONARY EXACERBATION Author keyword 18 48% 1% 28
4 INHALED ANTIBIOTICS Author keyword 17 49% 1% 25
5 TOBRAMYCIN SOLUTION FOR INHALATION Author keyword 11 78% 0% 7
6 PULMONARY EXACERBATIONS Author keyword 10 52% 1% 13
7 TOBRAMYCIN Author keyword 7 12% 2% 51
8 INHALED ANTIBIOTIC Author keyword 6 80% 0% 4
9 SECT PEDIAT PULMONOL ALLERGY SLEEP MED Address 6 80% 0% 4
10 AZTREONAM LYSINE Author keyword 6 71% 0% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 INHALED TOBRAMYCIN 21 85% 0% 11 Search INHALED+TOBRAMYCIN Search INHALED+TOBRAMYCIN
2 PULMONARY EXACERBATION 18 48% 1% 28 Search PULMONARY+EXACERBATION Search PULMONARY+EXACERBATION
3 INHALED ANTIBIOTICS 17 49% 1% 25 Search INHALED+ANTIBIOTICS Search INHALED+ANTIBIOTICS
4 TOBRAMYCIN SOLUTION FOR INHALATION 11 78% 0% 7 Search TOBRAMYCIN+SOLUTION+FOR+INHALATION Search TOBRAMYCIN+SOLUTION+FOR+INHALATION
5 PULMONARY EXACERBATIONS 10 52% 1% 13 Search PULMONARY+EXACERBATIONS Search PULMONARY+EXACERBATIONS
6 TOBRAMYCIN 7 12% 2% 51 Search TOBRAMYCIN Search TOBRAMYCIN
7 INHALED ANTIBIOTIC 6 80% 0% 4 Search INHALED+ANTIBIOTIC Search INHALED+ANTIBIOTIC
8 AZTREONAM LYSINE 6 71% 0% 5 Search AZTREONAM+LYSINE Search AZTREONAM+LYSINE
9 NEBULIZED ANTIBIOTICS 5 63% 0% 5 Search NEBULIZED+ANTIBIOTICS Search NEBULIZED+ANTIBIOTICS
10 PSEUDOMONAS INFECTIONS DRUG THERAPY 5 63% 0% 5 Search PSEUDOMONAS+INFECTIONS+DRUG+THERAPY Search PSEUDOMONAS+INFECTIONS+DRUG+THERAPY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INHALED TOBRAMYCIN 119 61% 5% 126
2 OROPHARYNGEAL CULTURES 77 75% 2% 55
3 AEROSOLIZED TOBRAMYCIN 50 64% 2% 49
4 PSEUDOMONAS AERUGINOSA INFECTION 42 30% 5% 121
5 INHALED AZTREONAM LYSINE 36 65% 1% 34
6 HIGH DOSE IBUPROFEN 27 63% 1% 27
7 PULMONARY EXACERBATIONS 23 38% 2% 49
8 AIRWAY PSEUDOMONAS 22 56% 1% 27
9 NEBULIZED TOBRAMYCIN 22 81% 1% 13
10 INHALED ANTIBIOTICS 21 90% 0% 9

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 JOURNAL OF CYSTIC FIBROSIS 25 17% 6% 136

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Pathophysiology and management of pulmonary infections in cystic fibrosis 2003 695 428 32%
Cystic fibrosis pulmonary guidelines - Chronic medications for maintenance of lung health 2007 220 89 57%
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies 2012 66 125 54%
Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials 2013 15 25 88%
Cystic fibrosis 2003 451 103 29%
Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis 2011 58 40 68%
Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis as a diagnostic tool: A systematic review 2014 4 34 91%
Cystic fibrosis: a mucosal immunodeficiency syndrome 2012 94 175 26%
Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa 2013 9 30 100%
Exacerbations in cystic fibrosis center dot 1: Epidemiology and pathogenesis 2007 135 108 45%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SECT PEDIAT PULMONOL ALLERGY SLEEP MED 6 80% 0.2% 4
2 PEDIAT PULMONOL ALLERGOL 6 33% 0.6% 14
3 CYST FIBROSIS FDN 5 60% 0.3% 6
4 INFORMAT SYST ORG 4 75% 0.1% 3
5 THER EUT DEV NETWORK 4 75% 0.1% 3
6 THER EUT DEV NETWORK COORDINATING 4 75% 0.1% 3
7 CYST FIBROSIS FDN THER EUT DEV NETWORK COORDINAT 3 100% 0.1% 3
8 CHILD HLTH OBSTET GYNAECOL COG 3 60% 0.1% 3
9 CRCM ADULTES 3 60% 0.1% 3
10 PAEDIAT CYST FIBROSIS UNIT 3 60% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000220014 SAHMRI INFECT IMMUN THEME//CYST FIBROSIS UNIT//OROPHARYNGEAL FLORA
2 0.0000198787 RHDNASE//DORNASE ALFA//MUCUS VISCOELASTICITY
3 0.0000171539 CYSTIC FIBROSIS PARANASAL SINUSES//NASAL POLYPS COMPLICATIONS DRUG THERAPY//SINUS DEVELOPMENT
4 0.0000159617 RD BIOSCI//PSEUDOMONAS VACCINE//PNEUMONIA CLIN
5 0.0000147395 REG PAEDIAT CF UNIT//ADOLESCENTS AND ADULTS//ADULT CYST FIBROSIS UNIT
6 0.0000119477 OE 6710//PYOCIN TYPING//KLIN FOR ERGRP
7 0.0000118722 REFERRAL ADULT CYST FIBROSIS//UNITE EXPLORAT FONCTIONNELLES P PEDIAT//MODIFIED SHUTTLE TEST
8 0.0000112925 BRONCHIECTASIS//MIDDLE LOBE SYNDROME//GUANGZHOU P DISAFFILIATED HOSP 1
9 0.0000110965 CYSTIC FIBROSIS RELATED DIABETES//CYSTIC FIBROSIS RELATED DIABETES CFRD//JOURNAL OF CYSTIC FIBROSIS
10 0.0000105835 CYSTIC FIBROSIS//CFTR GENE//CBAVD